| Year |
Citation |
Score |
| 2012 |
Sathigari SK, Radhakrishnan VK, Davis VA, Parsons DL, Babu RJ. Amorphous-state characterization of efavirenz--polymer hot-melt extrusion systems for dissolution enhancement. Journal of Pharmaceutical Sciences. 101: 3456-64. PMID 22437488 DOI: 10.1002/Jps.23125 |
0.701 |
|
| 2012 |
Kolli CS, Xiao J, Parsons DL, Babu RJ. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate. Drug Development and Industrial Pharmacy. 38: 571-6. PMID 21980925 DOI: 10.3109/03639045.2011.617753 |
0.365 |
|
| 2011 |
Chadha G, Sathigari S, Parsons DL, Jayachandra Babu R. In vitro percutaneous absorption of genistein from topical gels through human skin. Drug Development and Industrial Pharmacy. 37: 498-505. PMID 21126208 DOI: 10.3109/03639045.2010.525238 |
0.687 |
|
| 2010 |
Kolli CS, Chadha G, Xiao J, Parsons DL, Babu RJ. Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro. Journal of Drug Targeting. 18: 657-64. PMID 20038213 DOI: 10.3109/10611860903494237 |
0.423 |
|
| 2009 |
Phillip Lee YH, Sathigari S, Jean Lin YJ, Ravis WR, Chadha G, Parsons DL, Rangari VK, Wright N, Babu RJ. Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies. Drug Development and Industrial Pharmacy. 35: 1113-20. PMID 19640249 DOI: 10.1080/03639040902783074 |
0.707 |
|
| 2009 |
Jayachandra Babu R, Ravis WR, Duran SH, Schumacher J, Cox E, Stahl R, Jones K, Jean Lin YJ, Phillip Lee YH, Parsons DL, Portman EM, Brown SC. Enhancement of transdermal delivery of phenylbutazone from liposomal gel formulations through deer skin. Journal of Veterinary Pharmacology and Therapeutics. 32: 388-92. PMID 19614844 DOI: 10.1111/J.1365-2885.2009.01060.X |
0.45 |
|
| 2009 |
Sathigari S, Chadha G, Lee YH, Wright N, Parsons DL, Rangari VK, Fasina O, Babu RJ. Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes. Aaps Pharmscitech. 10: 81-7. PMID 19148759 DOI: 10.1208/S12249-008-9180-3 |
0.698 |
|
| 2002 |
Zhang L, Parsons DL, Navarre C, Kompella UB. Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur. Journal of Controlled Release : Official Journal of the Controlled Release Society. 85: 73-81. PMID 12480313 DOI: 10.1016/S0168-3659(02)00273-0 |
0.309 |
|
| 1992 |
Shah IG, Parsons DL. Human albumin binding of tamoxifen in the presence of a perfluorochemical erythrocyte substitute. The Journal of Pharmacy and Pharmacology. 43: 790-3. PMID 1686908 DOI: 10.1111/j.2042-7158.1991.tb03483.x |
0.381 |
|
| 1991 |
Ravis WR, Hoke JF, Parsons DL. Perfluorochemical erythrocyte substitutes: disposition and effects on drug distribution and elimination. Drug Metabolism Reviews. 23: 375-411. PMID 1935577 DOI: 10.3109/03602539109029765 |
0.431 |
|
| 1988 |
Graben RD, Parsons DL. Effects of a perfluorochemical blood substitute on diazepam binding by human albumin. The Journal of Pharmacy and Pharmacology. 40: 684-8. PMID 2907533 |
0.493 |
|
| 1986 |
Parsons DL. Effect of a perfluorochemical emulsion on prednisolone binding by human albumin. Biochemical Pharmacology. 35: 1395-7. PMID 3964304 DOI: 10.1016/0006-2952(86)90288-1 |
0.339 |
|
| 1976 |
Vallner JJ, Sternson LA, Parsons DL. Interaction of dantrolene sodium with human serum albumin. Journal of Pharmaceutical Sciences. 65: 873-7. PMID 932973 DOI: 10.1002/jps.2600650618 |
0.396 |
|
| Show low-probability matches. |